Citius Pharmaceuticals, Inc. (CTXR): Price and Financial Metrics

Citius Pharmaceuticals, Inc. (CTXR): $0.20

0.13 (-39.10%)

POWR Rating

Component Grades

Momentum

F

Stability

D

Sentiment

Quality

D

Add CTXR to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#329 of 337

in industry

CTXR Price/Volume Stats

Current price $0.20 52-week high $1.07
Prev. close $0.33 52-week low $0.19
Day low $0.19 Volume 11,263,700
Day high $0.33 Avg. volume 1,503,469
50-day MA $0.43 Dividend yield N/A
200-day MA $0.65 Market Cap 36.15M

CTXR Stock Price Chart Interactive Chart >


Citius Pharmaceuticals, Inc. (CTXR) Company Bio


Citius Pharmaceuticals, Inc., a specialty pharmaceutical company, develops and commercializes critical care products. It primarily focuses on developing anti-infective, cancer care, prescription, and mesenchymal stem cell therapy products. The company is developing Mino-Lok, an antibiotic lock solution used to treat patients with catheter-related bloodstream infections by salvaging the infected catheter, which is in Phase III clinical trials; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a corticosteroid-lidocaine topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; and NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory disease syndrome. Citius Pharmaceuticals, Inc. was founded in 2007 and is headquartered in Cranford, New Jersey.


CTXR Latest News Stream


Event/Time News Detail
Loading, please wait...

CTXR Latest Social Stream


Loading social stream, please wait...

View Full CTXR Social Stream

CTXR Price Returns

1-mo -48.85%
3-mo -66.85%
6-mo -73.06%
1-year -74.12%
3-year -88.30%
5-year -56.52%
YTD -73.56%
2023 -4.24%
2022 -48.70%
2021 50.98%
2020 0.00%
2019 -1.92%

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!